Home
Conditions
Lymphoma, Follicular

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,362 public trials 202 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Not Yet Recruiting

Effect of Inhaled Nitric Oxide Therapy in Adults With Moderate-to-Severe Acute Respiratory Distress Syndrome

NCT07334873

Conditions: ARDS (Moderate or Severe), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Transcatheter Edge-to-Edge Repair In Moderate and Exertional-Induced Severe MR (TIMER)

NCT07197021

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).

NCT07191249

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma

NCT07187960

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China

Gansu Provincial Hospital Lanzhou, Gansu, China

Sun Yet-Sen University Cancer Certer Guangzhou, Guangdong, China

View all 28 locations

View Trial Details

Not Yet Recruiting

Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma

NCT07168291

Conditions: Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma (DLBCL), +18 more
Locations: First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China

View Trial Details

Not Yet Recruiting

Evaluating Near-infrared Spectroscopy Devices for Monitoring Traumatic Brain Injury

NCT07106216

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

PGx Medication Safety Reviews of Persons With IDD

NCT07092852

Conditions: Developmental Disabilities, Developmental Disability, Hemic and Lymphatic Diseases, +19 more
Locations: GalenusRx, Inc. Montverde, Florida, United States

CP Unlimited The Bronx, New York, United States

View Trial Details

Not Yet Recruiting

A Multicenter, Single-Arm, Open-Label, Phase II Trial of Mosunetuzumab in Combination With Tislelizumab for r/r FL

NCT07031700

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma

NCT07024147

Conditions: B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
Locations: Beijing cancer hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Management of Undernutrition on Discharge From Hospital by Dieticians and Physical Activity Teachers at Home

NCT06976827

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations: Centre hospitalier Henri Mondor d'Aurillac Aurillac, France

View Trial Details

Lymphoma, Follicular

Lymphoma, Follicular trial results

Related conditions